BioSante closes underwritten open public offering of common stock BioSante Pharmaceuticals viagra Receptfritt Denmark.

BioSante closes underwritten open public offering of common stock BioSante Pharmaceuticals, Inc. today announced the closing of its underwritten community giving of 16.0 million shares of common stock at a open public offering price of $3 viagra Receptfritt Denmark .00 per share, for total gross proceeds of $48.0 million before underwriting commissions and discounts. The offering led to net proceeds to BioSante of around $45.0 million. All the shares in the providing were offered by BioSante. BioSante offers granted the underwriters a 30-day time option to buy up to an aggregate of 2.4 million extra shares of common share at the same cost to cover over-allotments, if any.S. Food and Medication Administration Special Process Assessment ..

køb viagra online danmark

Infusion Solutions segment income was $247.0 million in the next quarter of 2015 in comparison with $230.5 million for the same period in 2014. The 7.1 percent increase was driven primarily by continued strong organic development particularly in chronic, nourishment and other therapies. Consolidated gross revenue for the second one fourth of 2015 was $66.0 million, or 25.1 percent of revenue, in comparison to $65.4 million, or 26.4 percent of revenue, for the next quarter of 2014. The upsurge in gross revenue dollars was because of revenue development in the Infusion Solutions segment partially offset by lower PBM Solutions gross profit.

Other entries from category "clinical":

Random entries